Katja Hanack

Professorship

University of Potsdam

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Katja Hanack is a Professor at the University of Potsdam, Germany. Her research focuses on immunology and virology, particularly in the development of vaccines and diagnostic tools for SARS-CoV-2 and neurodegenerative diseases. Recent publications include work on immune shields against SARS-CoV-2 variants and innovative methods for producing virus-like particles and antibodies.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Ramasamy Paulmurugan

Associate Professor

Stanford University

UNITED STATES

View details

Sławomir Filipek

University of Warsaw

POLAND

View details

Christoph Harms

Associate Professor 'Molecular Stroke Research' (tenured, Univ.-Prof.)

GERMANY

View details

Manfred Gossen

GERMANY

View details

Lorenz Adrian

Department Head

Helmholtz Centre for Environmental Research - UFZ

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katja Hanack

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Cross-variant immune shield: computational multiepitope vaccine design against B.617.2 to Omicron sub-lineages in SARS-CoV-2

Development of an optimized cell-based selection system for phage display libraries

Automated determination of 8-OHdG in cells and tissue via immunofluorescence using a specially created antibody

MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review

An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line

Comment on “Monoclonal Antibody Discovery Based on Precise Selection of Single Transgenic Hybridomas with an On-Cell-Surface and Antigen-Specific Anchor”

tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2

SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform

A switchable secrete-and-capture system enables efficient selection of Pichia pastoris clones producing high yields of Fab fragments

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications

Evaluation of Immune Evasion in SARS-CoV-2 Delta and Omicron variants

Three-dimensional cell culture approach for in vitro immunization and the production of monoclonal antibodies.

Three-dimensional cell culture approach for in vitro immunization and the production of monoclonal antibodies

Novel Anti Double-Stranded Nucleic Acids Full-Length Recombinant Camelid Heavy-Chain Antibody for the Detection of miRNA

Pyridinium Alkynylanthracenes as Sensitizers for Photodynamic Therapy

A New Workflow to Generate Monoclonal Antibodies against Microorganisms

Collaborators (5)

Ramasamy Paulmurugan

Sławomir Filipek

Christoph Harms

Manfred Gossen

Lorenz Adrian

Make your next move.